Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suviplast is a transdermal herbal patch developed by the Ukrainian company Omnifarma Kiev. It is formulated with a combination of plant extracts, primarily comfrey (*Symphytum officinale*) and arnica (*Arnica montana*), which are recognized for their anti-inflammatory, analgesic, and tissue-regenerative properties. The patch is designed to provide localized relief for muscle and joint pain, swelling, and inflammation associated with injuries or chronic musculoskeletal conditions. By utilizing a transdermal delivery mechanism, Suviplast ensures a steady release of active phyto-compounds directly to the site of discomfort, offering a convenient alternative to topical gels or systemic medications. It is approved for use in Ukraine as a localized treatment for musculoskeletal disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Suviplast.